Literature DB >> 8617790

Suppression of interleukin-1 beta-converting enzyme-mediated cell death by insulin-like growth factor.

Y Jung1, M Miura, J Yuan.   

Abstract

COS cells are resistant to cell death induced either by interleukin-1beta-converting enzyme (*ICE) and ICE homolog (ICH-1L) overexpression or by serum deprivation. COS cells deprived of serum undergo apoptosis after transfection with an ICE expression construct, but not an ICH-1L construct. ICE-mediated apoptosis of COS cells in serum-free medium is suppressed by insulin-like growth factor (IGF)-1 and insulin. Viability of Rat-1 cell line (Rat-1/ICE) expressing low levels of ICE-LacZ fusion protein is lower than those of cell lines expressing either both Bcl-2 and ICE or mutant ICEGly-->Ser during serum deprivation. Enzymatic activation and processing of ICE are observed in cells induced to die by serum deprivation, which are suppressed by IGF-1. IGF-1 or insulin suppresses ICE-mediated cell death without affecting the expression levels of Bcl-2, Bcl-x, or Bax. Taken together, these results indicate that ICE is activated by growth factor deprivation, and IGF-1 is able to suppress ICE-mediated cell death through a mechanism independent of the expression of Bcl-2, Bcl-x, or Bax.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617790     DOI: 10.1074/jbc.271.9.5112

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis.

Authors:  Y E Chin; M Kitagawa; K Kuida; R A Flavell; X Y Fu
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy.

Authors:  Q Li; B Li; X Wang; A Leri; K P Jana; Y Liu; J Kajstura; R Baserga; P Anversa
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  The phosphoinositide 3-OH kinase/AKT2 pathway as a critical target for farnesyltransferase inhibitor-induced apoptosis.

Authors:  K Jiang; D Coppola; N C Crespo; S V Nicosia; A D Hamilton; S M Sebti; J Q Cheng
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

4.  The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal.

Authors:  M Prisco; A Hongo; M G Rizzo; A Sacchi; R Baserga
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

5.  Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt.

Authors:  G Kulik; A Klippel; M J Weber
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

6.  Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis.

Authors:  F Peruzzi; M Prisco; M Dews; P Salomoni; E Grassilli; G Romano; B Calabretta; R Baserga
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

7.  Insulin-like growth factor-I overexpression attenuates cerebellar apoptosis by altering the expression of Bcl family proteins in a developmentally specific manner.

Authors:  D Chrysis; A S Calikoglu; P Ye; A J D'Ercole
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

Review 8.  The p53/IGF-1 receptor axis in the regulation of programmed cell death.

Authors:  M Neuberg; L Buckbinder; B Seizinger; N Kley
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

9.  Imaging and therapy of experimental schwannomas using HSV amplicon vector-encoding apoptotic protein under Schwann cell promoter.

Authors:  S Prabhakar; G J Brenner; B Sung; S M Messerli; J Mao; M Sena-Esteves; A Stemmer-Rachamimov; B Tannous; X O Breakefield
Journal:  Cancer Gene Ther       Date:  2009-10-16       Impact factor: 5.987

10.  Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions.

Authors:  Leonardo Elia; Riccardo Contu; Manuela Quintavalle; Francesca Varrone; Cristina Chimenti; Matteo Antonio Russo; Vincenzo Cimino; Laura De Marinis; Andrea Frustaci; Daniele Catalucci; Gianluigi Condorelli
Journal:  Circulation       Date:  2009-11-23       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.